Arena Optimistic About Lorcaserin But Analysts More Reserved

Arena Pharmaceuticals argues it has the necessary safety data to convince an FDA advisory committee to recommend approval of its key drug, a weight loss treatment.

More from Archive

More from Pink Sheet